-
Mashup Score: 3
Treatment paradigms may soon be shifting in head and neck cancer, as recent research indicates that lower doses of chemoradiotherapy may be appropriate for some patients.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 10
Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
Phase 3 trial results on a precision radiotherapy technique support a ‘new gold standard’ for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after radiotherapy, without impacting the success of treatment.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8EORTC's Presence At ESMO 2023 2023 - EORTC - 7 month(s) ago
New findings and upcoming EORTC trials in lung, head and neck, breast and rare cancers will be presented at ESMO 2023 in Madrid, highlighting EORTC’s
Source: www.eortc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Jennifer Grandis, MD, is a surgeon-scientist who is anotolaryngologist and associate vice chancellor forclinical and translational research at UCSF. Sheis a …
Source: www.youtube.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Patient hails new UW Health dry mouth treatment a 'game-changer' - 7 month(s) ago
Dry mouth can cause dental and salivary gland concerns.
Source: spectrumnews1.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
Immunotherapy can extend the response of some head and neck tumours to treatment, maintaining the anti-tumour effects and preventing them from growing or spreading for longer, a study reports.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0EA3202 Home Page - ECOG-ACRIN Cancer Research Group - 7 month(s) ago
Patient must have histologically confirmed squamous cell carcinoma of the head and neck (HNSCC) (excluding SCC of salivary glands, Epstein-Barr virus [EBV]-associated nasopharynx and skin)Patient must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1. Measurements must be obtained within 4 weeks prior to randomizationPatient must be >= 18…
Source: ECOG-ACRIN Cancer Research GroupCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Matching cancer patients to treatment based on their levels of a key immune protein may allow doctors to select those who would benefit most from the combination of immunotherapy and chemotherapy, researchers report.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0PET/CT Follow-Up May Confer Survival Benefit in Head and Neck Cancer - 9 month(s) ago
Annual follow-up with 18FDG-PET/CT may improve survival, as compared to conventional follow-up, in patients with head and neck cancer.
Source: www.oncologynurseadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
For patients with #headandneckcancer, a one-size-fits-all chemoradiotherapy treatment is not the best approach, according to an expert from @MSKCancerCenter. Read to Learn More: https://t.co/hVmM18aVL6